Diabetic ketoacidosis induced by a single dose of pembrolizumab
- 20 October 2018
- journal article
- research article
- Published by Elsevier BV in The American Journal of Emergency Medicine
- Vol. 37 (2), 376.e1-376.e2
- https://doi.org/10.1016/j.ajem.2018.10.040
Abstract
No abstract availableKeywords
This publication has 7 references indexed in Scilit:
- Autoimmune Diabetes Associated With Pembrolizumab: A Review of Published Case ReportsWorld Journal of Oncology, 2018
- PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical OutcomeFrontiers in Pharmacology, 2017
- Adverse Events Associated with Immune Checkpoint Blockade in Patients with Cancer: A Systematic Review of Case ReportsPLOS ONE, 2016
- Immune checkpoint inhibitor‐related hypophysitis and endocrine dysfunction: clinical reviewClinical Endocrinology, 2016
- Anti-PD1 Pembrolizumab Can Induce Exceptional Fulminant Type 1 DiabetesDiabetes Care, 2015
- Precipitation of Autoimmune Diabetes With Anti-PD-1 ImmunotherapyDiabetes Care, 2015
- The reproductive endocrinology of the menopausal transitionSteroids, 2011